scholarly journals Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues

2011 ◽  
Vol 1 (1) ◽  
pp. 51-58 ◽  
Author(s):  
Guangwen Ren ◽  
Xiaodong Chen ◽  
Fengping Dong ◽  
Wenzhao Li ◽  
Xiaohui Ren ◽  
...  
2017 ◽  
Vol 6 (12) ◽  
pp. 2173-2185 ◽  
Author(s):  
Rebekah M. Samsonraj ◽  
Michael Raghunath ◽  
Victor Nurcombe ◽  
James H. Hui ◽  
Andre J. van Wijnen ◽  
...  

2011 ◽  
Vol 1 (1) ◽  
pp. 59-63 ◽  
Author(s):  
Juan Domínguez-Bendala ◽  
Giacomo Lanzoni ◽  
Luca Inverardi ◽  
Camillo Ricordi

Stem Cells ◽  
2019 ◽  
Vol 37 (10) ◽  
pp. 1252-1260 ◽  
Author(s):  
Se-Young Oh ◽  
Young Min Choi ◽  
Ha Yeong Kim ◽  
Yoon Shin Park ◽  
Sung-Chul Jung ◽  
...  

2012 ◽  
Vol 1 (2) ◽  
pp. 142-149 ◽  
Author(s):  
Scott Maxson ◽  
Erasmo A. Lopez ◽  
Dana Yoo ◽  
Alla Danilkovitch-Miagkova ◽  
Michelle A. LeRoux

2017 ◽  
Vol 4 (08) ◽  
Author(s):  
Phuc Van Pham

Extracellular vesicles (EVs) from mesenchymal stem cells (MSCs) are microvesicles produced from cells throughout their life. From research over recent years, there has been greater understanding about EVs, including their physiological characteristics and the role they play in cell targets. Indeed, EVs carry information (in the form of RNA, DNA and protein) to cell targets. Some of their main biological properties include angiogenesis and immune-modulation. Therefore, these properties can be exploited to treat various diseases, including bone disorders, spinal cord injury and diabetes mellitus. Recently, new methods have been developed to isolate and enrich EVs with high performance and low-toxicity. Thus, EVs have emerged as the new generation of stem cell therapy. This concise review aims to highlight some recent achievements of EVs in preclinical and clinical applications.


Stem Cells ◽  
2019 ◽  
Vol 37 (7) ◽  
pp. 855-864 ◽  
Author(s):  
Anna Andrzejewska ◽  
Barbara Lukomska ◽  
Miroslaw Janowski

Sign in / Sign up

Export Citation Format

Share Document